Crossmark

An immune tolerance approach using transient low-dose methotrexate in the ERT-naïve setting of patients treated with a therapeutic protein: experience in infantile-onset Pompe disease

Crossref DOI link: https://doi.org/10.1038/s41436-018-0270-7

Published Print: 2019-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Kazi, Zoheb B.

Desai, Ankit K.

Troxler, R. Bradley

Kronn, David

Packman, Seymour

Sabbadini, Marta

Rizzo, William B.

Scherer, Katalin

Abdul-Rahman, Omar

Tanpaiboon, Pranoot

Nampoothiri, Sheela

Gupta, Neerja

Feigenbaum, Annette

Niyazov, Dmitriy M.

Sherry, Langston

Segel, Reeval

McVie-Wylie, Alison

Sung, Crystal

Joseph, Alexandra M.

Richards, Susan

Kishnani, Priya S.
License Information

Text and Data Mining valid from 2019-04-01

Text and Data Mining valid from 2019-04-01

Version of Record valid from 2022-01-19
More Information

This article is maintained by: Elsevier

Article Title: An immune tolerance approach using transient low-dose methotrexate in the ERT-naïve setting of patients treated with a therapeutic protein: experience in infantile-onset Pompe disease

Journal Title: Genetics in Medicine

CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/s41436-018-0270-7

Content Type: article

Copyright: © 2019, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics

Document is current

Any future updates will be listed below